MARKET

EPIX

EPIX

Essa Pharma
NASDAQ
8.56
-0.29
-3.28%
After Hours: 8.40 -0.16 -1.87% 18:05 03/27 EDT
OPEN
8.94
PREV CLOSE
8.85
HIGH
9.19
LOW
8.50
VOLUME
139.38K
TURNOVER
0
52 WEEK HIGH
11.67
52 WEEK LOW
2.560
MARKET CAP
378.68M
P/E (TTM)
-14.6300
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at EPIX last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at EPIX last week (0311-0315)?
Weekly Report · 03/18 11:01
Weekly Report: what happened at EPIX last week (0304-0308)?
Weekly Report · 03/11 10:58
ESSA Pharma Shareholders Show Strong Support
TipRanks · 03/08 01:37
EXCLUSIVE-Norway's wealth fund pushes for more women on emerging market company boards
Norway's $1.6 trillion sovereign wealth fund pushes for more women on emerging market company boards. The fund holds stakes in around 8,800 companies globally, owns 1.5% of all listed stocks. Since 2021, the fund has pushed companies to boost the number of women on their boards. It will call on emerging markets companies in which it invests to appoint more women to their boards for first time.
Reuters · 03/06 09:00
Weekly Report: what happened at EPIX last week (0226-0301)?
Weekly Report · 03/04 11:01
Weekly Report: what happened at EPIX last week (0219-0223)?
Weekly Report · 02/26 11:12
Weekly Report: what happened at EPIX last week (0212-0216)?
Weekly Report · 02/19 11:14
More
About EPIX
ESSA Pharma Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing proprietary therapies for the treatment of patients with prostate cancer. Its lead candidate, EPI-7386, is an oral, small molecule that inhibits the N-terminal domain of the androgen receptor (AR). The Company is completing the initial Phase I clinical development of EPI-7386 as a monotherapy treatment for patients with metastatic castration-resistant prostate cancer (mCRPC). The Company is also developing ANITen bAsed Chimera (ANITAC) AR NTD degraders to suppress androgen biology.

Webull offers ESSA Pharma Inc stock information, including NASDAQ: EPIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EPIX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EPIX stock methods without spending real money on the virtual paper trading platform.